Challenges and issues of SARS-CoV-2 pool testing - Authors' reply.
作者信息
Lohse Stefan, Pfuhl Thorsten, Berkó-Göttel Barbara, Gärtner Barbara, Becker Sören L, Schneitler Sophie, Smola Sigrun
机构信息
Institute of Virology, Saarland University Medical Center, 66421 Homburg, Germany.
Institute of Medical Microbiology and Hygiene, Saarland University Medical Center, 66421 Homburg, Germany.
出版信息
Lancet Infect Dis. 2020 Nov;20(11):1234-1235. doi: 10.1016/S1473-3099(20)30455-2. Epub 2020 Jul 14.
Abstract
摘要
相似文献
1
Challenges and issues of SARS-CoV-2 pool testing - Authors' reply.
Lancet Infect Dis. 2020 Nov;20(11):1234-1235. doi: 10.1016/S1473-3099(20)30455-2. Epub 2020 Jul 14.
2
Challenges and issues of SARS-CoV-2 pool testing.
Lancet Infect Dis. 2020 Nov;20(11):1233-1234. doi: 10.1016/S1473-3099(20)30467-9. Epub 2020 Jul 14.
3
Challenges and issues of SARS-CoV-2 pool testing.
Lancet Infect Dis. 2020 Nov;20(11):1233. doi: 10.1016/S1473-3099(20)30463-1. Epub 2020 Jul 14.
4
Challenges and issues of SARS-CoV-2 pool testing.
Lancet Infect Dis. 2020 Nov;20(11):1232-1233. doi: 10.1016/S1473-3099(20)30516-8. Epub 2020 Jul 14.
5
Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
Lancet. 2020 May 30;395(10238):e100. doi: 10.1016/S0140-6736(20)31185-5. Epub 2020 May 19.
6
SARS-CoV-2 shedding and infectivity - Authors' reply.
Lancet. 2020 Apr 25;395(10233):1340. doi: 10.1016/S0140-6736(20)30869-2. Epub 2020 Apr 15.
7
Authors' response: Plenty of coronaviruses but no SARS-CoV-2.
Euro Surveill. 2020 Feb;25(8). doi: 10.2807/1560-7917.ES.2020.25.8.2000197.
8
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
N Engl J Med. 2020 Oct 22;383(17):1697-1698. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
9
Stability and Viability of SARS-CoV-2. Reply.
N Engl J Med. 2020 May 14;382(20):1965-1966. doi: 10.1056/NEJMc2007942. Epub 2020 Apr 13.
10
Reply to: SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases.
Mov Disord. 2020 Jul;35(7):1106-1107. doi: 10.1002/mds.28178.
引用本文的文献
1
Evaluations of modes of pooling specimens for COVID-19 screened by quantitative PCR and droplet digital PCR.
Sci Rep. 2024 May 13;14(1):10923. doi: 10.1038/s41598-024-61631-0.
2
Pooling sputum samples for Xpert® MTB/RIF and Xpert® Ultra testing for TB diagnosis.
Public Health Action. 2023 Mar 21;13(1):12-16. doi: 10.5588/pha.22.0052.
3
Pooling samples to increase testing capacity with Xpert Xpress SARS-CoV-2 during the Covid-19 pandemic in Lao People's Democratic Republic.
PLoS One. 2022 Sep 29;17(9):e0275294. doi: 10.1371/journal.pone.0275294. eCollection 2022.
4
Monitoring for COVID-19 by universal testing in a homeless shelter in Germany: a prospective feasibility cohort study.
BMC Infect Dis. 2021 Dec 11;21(1):1241. doi: 10.1186/s12879-021-06945-4.
5
Detection of SARS-CoV-2 through pool testing for COVID-19: an integrative review.
Rev Soc Bras Med Trop. 2021 Nov 12;54:e0276. doi: 10.1590/0037-8682-0276-2021. eCollection 2021.
6
Sample pooling: burden or solution?
Clin Microbiol Infect. 2021 Sep;27(9):1212-1220. doi: 10.1016/j.cmi.2021.04.007. Epub 2021 Apr 18.
本文引用的文献
1
Pooling of samples for testing for SARS-CoV-2 in asymptomatic people.
Lancet Infect Dis. 2020 Nov;20(11):1231-1232. doi: 10.1016/S1473-3099(20)30362-5. Epub 2020 Apr 28.
2
Temporal dynamics in viral shedding and transmissibility of COVID-19.
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
3
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
Zotero 插件